| Factor Information | |
|---|---|
| Data ID | 3798 |
| Factor | ischemic time |
| Description | The ischemic time was also significantly longer in those with CHD (4.2±2 hours) than in those with other cardiac disease (3.2±1.2 hours) (P<0.001). |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | The purpose of our study was to describe the pretransplantation and posttransplantation courses of adults with CHD who undergo cardiac transplantation, to assess potential risk factors for a poor outcome, and to compare the posttransplantation outcome of adult patients with CHD with that of adult patients without CHD. |
| p Value | <0.001 |
| Conclusion | The ischemic time was also significantly longer in those with CHD (4.2±2 hours) than in those with other cardiac disease (3.2±1.2 hours) (P<0.001). |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 708 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | SV, PS/VSD/TGV/TOF, VSD/ASD/DILV, PS/other |
| Reference | |
|---|---|
| PMID | 10567304 |
| Year | 1999 |
| Title | Outcome After Orthotopic Cardiac Transplantation in Adults With Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | Patient Population | |
| Region | New York, USA | |
| Method | reviewed | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | cardiac transplantation | |
| Group | patients with CHD(Treatment) | patients without CHD(Control) |
| Number | 24 | 33 |
| Age | 26 years (range, 18 to 56 years) | 31 years |
| Gender (Male: Female) | 17:7 | 28:5 |
| Marker Level | 4.2 ± 2 hours | 3.2 ±1.2 hours |
